Brabykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury

Pamella H. M. Wang, Gabriela Campanholle, Marcos A. Cenedeze et al. · 2008

Read Brabykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury by Pamella H. M. Wang, Gabriela Campanholle, Marcos A. Cenedeze et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003050.txt.

Description

Pamella Wang, Gabriela Campanholle, Marcos Cenedeze and co-authors tested blocking the bradykinin B1 receptor in kidney injury in 2008. The team had earlier shown mice lacking that receptor were protected against renal ischemia-reperfusion injury, damage when blood returns after a cutoff. A drug blocker could offer the same gain without gene deletion.

Here they analyze the effect of B1 antagonism on that injury and whether blocking or deleting the receptor shifts the response. The title states antagonism is beneficial. Published in PLOS ONE, the work supports a drug route to protect kidneys after transplant or shock.

Catalog record

CREATORPamella H. M. Wang, Gabriela Campanholle, Marcos A. Cenedeze et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003050

Browse the full library · About the Tower of Babel